Alliance Pharma Share News (APH)
APH Share
APH Share
APH Share
APH Share
APH
APH Share
APH Level 2
APH Live
APH Broker
APH Directors
APH Financial
APH
APH Short
APH
Last checked at -
Mon, 21st Mar 2022 15:22
Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Confirms that it is in talks with an unnamed third party for the acquisition of two products in the US. Should an acquisition take place the aggregate payment would come up to USD20 million at the most.
Current stock price: 111.80 pence
12-month change: up 32%
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
(Sharecast News) - Healthcare group Alliance Pharma said on Tuesday that first-half revenues had been impacted by the Covid-19 pandemic, principally in its prescription medicines business.
Read moreDIRECTOR DEALINGS: Alliance Pharma Chair Buys GBP100,000 In Shares
Read moreUK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreAlliance Pharma Withdraws Final Dividend Despite Strong 2019 Results
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreMultiple UK Companies Warn On Covid-19 With Dividends Suffering
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read more(Sharecast News) - International healthcare group Alliance Pharma said it had recorded some strong revenue growth in 2019 on Wednesday as well as a rapid reduction in net debt.
Read moreAlliance Pharma Annual Revenue Rises On Strong Product Performances
Read more(Sharecast News) - Alliance Pharma has reached agreement with Duchesnay of Canada to return the UK and EU licensing rights to 'Xonvea', a prescription medicine for the treatment of nausea and vomiting of pregnancy where conservative management has failed, it announced on Wednesday.
Read moreAlliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake
Read more
Last checked at